The pharmacy chain said the FDA is not recommending people stop taking the stomach-acid-reducing drugs yet. However, it is encouraging patrons who bought these products to return them for a refund.
Walmart will suspend sales of over-the-counter ranitidine products, including Zantac, after the Food and Drug Administration discovered an impurity that has been linked to cancer in the popular heartburn medicine.
In a statement Wednesday, Walmart said it will also halt sales of Equate and Member’s Mark brands of ranitidine. Customers who purchased the products from Walmart or Sam’s Club can return them for a refund.
The nation’s largest retailer joins CVS and Walgreens in suspending ranitidine sales after the FD revealed some pills contained “low levels” of a possible carcinogen called nitrosodimethylamine (NDMA).
Meanwhile, in a statement obtained by USA TODAY, Kroger said it is suspending sales of Zantac and its private-label equivalent at its stores nationwide. Customers can return purchased products to stores for a refund.
The FDA does not recommend users stop taking ranitidine products. Zantac maker Sanofi said it will continue shipping the drug to the U.S. Three other drugmakers – Apotex, Sandoz and GlaxoSmithKline – recalled generic versions of Zantac sold at Walgreens, Walmart and Rite Aid.
Zantac pulled over cancer risk: Should you keep taking it? Here’s what we know
The FDA advises consumers who take prescription versions of ranitidine to consult a medical professional if they want to stop using it. The agency said consumers using over-the-counter options should consider other medications approved for their condition.
Follow Brett Molina on Twitter: @brettmolina23.
Read or Share this story: https://www.usatoday.com/story/money/2019/10/02/walmart-halting-zantac-sales-over-possible-cancer-link/3839963002/